HIV & AIDS

Recombinase Brec1 trend-setting for future HIV therapy

Researchers at the Medical Faculty of the Technische Universität Dresden (TUD) and the Heinrich Pette Institute (HPI), Leibniz Institute for Experimental Virology succeeded in developing a designer recombinase (Brec1) that ...

HIV & AIDS

How HIV became a treatable, chronic disease

It has been almost 35 years since the world was introduced to the term AIDS. In the 1980s, researchers and physicians were trying to understand what was causing waves of strange infections and discovered it was a new virus ...

HIV & AIDS

HIV prevention pill may not need to be taken daily

(HealthDay)—New research suggests that men at risk for HIV, the virus that causes AIDS, can benefit from a preventive medication taken before and after sex instead of every day.

HIV & AIDS

Russia HIV infection bucks trends as World Aids Day marked

On a frigid evening on the outskirts of Moscow, two HIV-prevention activists unzip backpacks, pull out packs of hypodermic needles and start discretely approaching people leaving a nearby pharmacy with an offer that could ...

page 10 from 17